Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI
Published: 01 September 2020
-
Views:
56
-
Likes:
7
-
Views:
56
-
Likes:
7
-
Up Next
-
2m 4sPart 1 Welcome Kurt Huber
-
15m 14sPart 2 Pre-treatment in NSTE-ACS – Dead or Alive? Davide Capodanno
-
18m 1sPart 3 Choice of Antithrombotic Agent in ACS: REACT-ing to Recent Trials Stefan James
-
12m 18sPart 4 When to leave Aspirin behind? Roxana Mehran
Overview
In this series of videos Kurt Huber, Davide Capodanno, Stefan James and Roxana Mehran discuss Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI
Learning Objectives
- Review the clinical landscape for antiplatelet therapy in patients with ACS.
- Discuss recent data on DAPT for patients with ACS
- Provide expert insight on application in routine clinical practice
More from this programme
Part 2
Pre-treatment in NSTE-ACS – Dead or Alive?
Part 3
Choice of Antithrombotic Agent in ACS: REACT-ing to Recent Trials
Part 4
When to leave Aspirin behind?
| 1 session | |
| When to leave Aspirin behind? | Watch now |
Faculty Biographies
Stefan James
Dr Stefan James is Professor of Cardiology at Uppsala University and Scientific Director of Uppsala Clinical Research Center. He is a Senior Interventional Cardiologist at Uppsala University Hospital Sweden. He graduated from Uppsala University Medical School and completed specialist training in Uppsala. He has previously held positions at the Karolinska Hospital, the University Hospital Örebro and Duke Clinical Research Institute, Duke University.
Roxana Mehran
Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, FSCAI is Professor of Medicine and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai School of Medicine.
Dr. Mehran is currently Professor of Medicine, Cardiology and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai in New York. She is also Director of Interventional Cardiovascular Research and Clinical Trials at The Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai Hospital where, over the past five years, she has led the development of a globally-respected data and clinical coordination center to support large, multicenter, multinational clinical trials designed, by her team, to help clinicians improve outcomes and quality of life for patients undergoing interventional cardiovascular procedures. In recent years, her work has had a special emphasis on gaining a deeper…